PortfoliosLab logo

Brooklyn ImmunoTherapeutics, Inc. (BTX)

Equity · Currency in USD · Last updated Jun 28, 2022

Company Info

ISINUS1140821000
CUSIP114082100
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.59
Year Range$0.48 - $18.01
EMA (50)$0.92
EMA (200)$4.71
Average Volume$658.13K
Market Capitalization$33.03M

BTXShare Price Chart


Chart placeholderClick Calculate to get results

BTXPerformance

The chart shows the growth of $10,000 invested in Brooklyn ImmunoTherapeutics, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $65 for a total return of roughly -99.35%. All prices are adjusted for splits and dividends.


BTX (Brooklyn ImmunoTherapeutics, Inc.)
Benchmark (^GSPC)

BTXReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-12.63%-6.21%
YTD-85.96%-18.17%
6M-88.27%-17.47%
1Y-96.93%-8.89%
5Y-47.02%9.58%
10Y-32.19%10.95%

BTXMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

BTXSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Brooklyn ImmunoTherapeutics, Inc. Sharpe ratio is -1.11. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


BTX (Brooklyn ImmunoTherapeutics, Inc.)
Benchmark (^GSPC)

BTXDividend History


Brooklyn ImmunoTherapeutics, Inc. doesn't pay dividends

BTXDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


BTX (Brooklyn ImmunoTherapeutics, Inc.)
Benchmark (^GSPC)

BTXWorst Drawdowns

The table below shows the maximum drawdowns of the Brooklyn ImmunoTherapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Brooklyn ImmunoTherapeutics, Inc. is 99.71%, recorded on Jun 21, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.71%Dec 3, 20132115Jun 21, 2022
-81.1%Apr 27, 2010539Jun 26, 2012350Nov 22, 2013889
-17.65%Jan 15, 201024Feb 19, 201037Apr 14, 201061
-6.67%Jan 5, 20101Jan 5, 20103Jan 8, 20104
-3.87%Nov 29, 20131Nov 29, 20131Dec 2, 20132

BTXVolatility Chart

Current Brooklyn ImmunoTherapeutics, Inc. volatility is 107.74%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


BTX (Brooklyn ImmunoTherapeutics, Inc.)
Benchmark (^GSPC)

Portfolios with Brooklyn ImmunoTherapeutics, Inc.


Loading data...